Quick Heal Technologies (QUICKHEAL)₹152.44+0.67%Software Products
In the Sep 2026 quarter (consolidated), Quick Heal Technologies reported sales of ₹65.10 Cr, down 22.3% from Sep 2025, and net profit of ₹5.81 Cr, down 26.7% year on year. For the year to Mar 2026, sales were ₹262 Cr and net profit −₹11.02 Cr.
Company filings, consolidated accounts; latest reported quarter Sep 2026
| Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 82.18 | 80.24 | 70.52 | 73.69 | 70.79 | 65.33 | 57.44 | 83.76 | 71.78 | 48.83 | 45.14 | 65.10 |
| Expenses | 70.47 | 70.13 | 67.80 | 70.51 | 74.53 | 73.81 | 67.04 | 74.48 | 71.17 | 78.13 | 62.72 | 62.76 |
| Operating Profit | 11.59 | 10.02 | 2.58 | 3.06 | −3.76 | −8.45 | −9.71 | 9.21 | 0.44 | −29.27 | −17.53 | 2.29 |
| OPM % | 14.2% | 12.5% | 3.7% | 4.2% | −5.4% | −13.1% | −17.1% | 11.0% | 0.6% | −60.2% | −39.1% | 3.5% |
| Other Income | 4.16 | 6.85 | 5.08 | 5.22 | 4.92 | 5.62 | 5.77 | 4.39 | 8.98 | 3.76 | 14.14 | 8.37 |
| Interest | 0.00 | 0.12 | 0.06 | 0.06 | 0.05 | 0.07 | 0.05 | 0.06 | 0.07 | 0.04 | 0.00 | 0.54 |
| Depreciation | 3.25 | 3.19 | 2.80 | 3.16 | 3.40 | 3.64 | 2.97 | 3.29 | 3.60 | 4.08 | 3.86 | 5.80 |
| Profit before tax | 12.51 | 13.53 | 4.80 | 5.06 | −2.30 | −6.56 | −6.99 | 10.25 | 5.74 | −29.63 | −7.31 | 4.32 |
| Tax % | 19.8% | −3.6% | 16.2% | 18.2% | −104.7% | −50.5% | −21.3% | 23.1% | −14.9% | −32.8% | −27.9% | −33.9% |
| Net Profit | 10.08 | 14.08 | 4.04 | 4.16 | 0.12 | −3.26 | −5.52 | 7.93 | 6.62 | −19.97 | −5.29 | 5.81 |
| EPS (Rs) | 1.90 | 2.63 | 0.74 | 0.78 | 0.01 | −0.59 | −1.01 | 1.45 | 1.23 | −3.69 | −0.96 | 1.06 |
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 303 | 301 | 319 | 316 | 287 | 334 | 343 | 279 | 293 | 281 | 262 | 231 |
| Expenses | 201 | 210 | 198 | 187 | 195 | 192 | 235 | 277 | 275 | 287 | 290 | 275 |
| Operating Profit | 102 | 89.79 | 120 | 128 | 91.76 | 141 | 107 | 1.99 | 17.97 | −6.98 | −28.95 | −44.07 |
| OPM % | 34.0% | 29.9% | 37.9% | 40.9% | 32.0% | 42.0% | 30.9% | 0.7% | 6.0% | −2.4% | −11.0% | −19.1% |
| Other Income | 10.04 | 25.10 | 30.11 | 33.11 | 31.08 | 24.08 | 19.07 | 22.09 | 21.08 | 21.07 | 23.09 | 35.25 |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.65 |
| Depreciation | 24.05 | 31.07 | 27.08 | 24.08 | 22.05 | 19.05 | 17.05 | 16.05 | 13.03 | 13.03 | 14.03 | 17.34 |
| Profit before tax | 87.85 | 83.89 | 123 | 137 | 101 | 146 | 109 | 7.99 | 25.96 | 0.99 | −20.97 | −26.88 |
| Tax % | 34.0% | 37.1% | 33.0% | 33.1% | 27.1% | 27.0% | 23.0% | 20.0% | 8.1% | −404.0% | −47.0% | — |
| Exceptional items | 0.00 | −2.01 | 0.00 | 1.01 | 2.01 | 2.01 | 3.01 | 6.02 | 2.01 | 2.01 | 6.02 | — |
| Net Profit | 58.13 | 53.15 | 83.11 | 92.25 | 74.15 | 107 | 83.22 | 6.01 | 24.07 | 5.01 | −11.02 | −12.83 |
| EPS (Rs) | 8.28 | 7.58 | 11.80 | 13.00 | 11.60 | 16.65 | 14.35 | 1.22 | 4.54 | 0.92 | −2.02 | −2.36 |
| Dividend payout % | 30.0% | 33.1% | 25.1% | 15.0% | 35.0% | 24.0% | 31.1% | 207.1% | 66.1% | 0.0% | 0.0% | — |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 61.18 | 69.99 | 69.98 | 70.06 | 70.99 | 64.00 | 64.06 | 58.01 | 53.05 | 54.03 | 53.98 | 54.07 |
| Reserves | 271 | 559 | 592 | 653 | 719 | 580 | 688 | 570 | 367 | 383 | 387 | 382 |
| Borrowings | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Liabilities | 96.54 | 87.58 | 71.65 | 56.72 | 62.70 | 51.75 | 74.64 | 87.58 | 73.65 | 75.64 | 82.60 | 109 |
| Total Liabilities | 428 | 716 | 733 | 781 | 853 | 697 | 827 | 716 | 493 | 513 | 525 | 547 |
| Fixed Assets | 111 | 142 | 186 | 173 | 165 | 159 | 147 | 137 | 124 | 117 | 119 | 122 |
| CWIP | 74.24 | 55.10 | 14.04 | 14.04 | 11.03 | 3.01 | 2.01 | 0.00 | 0.00 | 3.01 | 0.00 | 0.00 |
| Investments | 130 | 115 | 182 | 307 | 390 | 310 | 417 | 319 | 198 | 190 | 179 | 213 |
| Other Assets | 113 | 404 | 352 | 286 | 287 | 224 | 262 | 260 | 170 | 202 | 225 | 211 |
| Inventories | 7.98 | 6.98 | 7.98 | 5.99 | 4.99 | 5.99 | 2.99 | 4.99 | 3.99 | 2.99 | 1.99 | 2.99 |
| Trade receivables | 64.82 | 91.88 | 96.74 | 103 | 125 | 113 | 151 | 172 | 123 | 132 | 167 | 138 |
| Cash & equivalents | 13.02 | 269 | 209 | 163 | 135 | 80.19 | 84.20 | 63.10 | 12.01 | 38.07 | 21.02 | 13.02 |
| Total Assets | 428 | 716 | 733 | 781 | 853 | 697 | 827 | 716 | 493 | 513 | 525 | 547 |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operating activity | 77.06 | 78.03 | 36.04 | 93.97 | 61.04 | 71.02 | 99.04 | 80.06 | 31.02 | 18.02 | −22.03 | 15.02 |
| Cash from investing activity | −53.08 | −163 | −73.02 | −122 | −37.01 | 148 | −92.08 | 126 | 185 | 6.01 | 16.03 | −26.01 |
| Cash from financing activity | −17.92 | 188 | −19.93 | −18.94 | −23.90 | −220 | 0.00 | −213 | −211 | 1.99 | −9.96 | 2.99 |
| Net cash flow | 6.98 | 104 | −56.83 | −46.85 | 0.99 | −2.99 | 5.99 | −8.97 | 3.99 | 25.91 | −16.97 | −7.98 |
| Capex | 66.05 | 36.05 | 35.03 | 14.02 | 11.01 | 11.02 | 9.01 | 6.01 | 4.01 | 8.01 | 14.01 | 15.01 |
| Free cash flow | 10.97 | 41.89 | 1.99 | 79.88 | 53.91 | 59.91 | 89.83 | 78.84 | 31.94 | 11.97 | −35.93 | 5.99 |
| CFO / OP % | 116.0% | 92.0% | 73.0% | 100.0% | 91.0% | 114.0% | 90.0% | 106.0% | 2,064.0% | 102.0% | 325.0% | −80.0% |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor days | 82 | 111 | 117 | 117 | 144 | 143 | 164 | 183 | 160 | 164 | 217 | 191 |
| Inventory days | 181 | 144 | — | — | — | — | — | — | — | — | — | — |
| Days payable | 865 | 1,104 | — | — | — | — | — | — | — | — | — | — |
| Cash conversion cycle | −599 | −846 | 119 | 119 | 146 | 145 | 166 | 185 | 162 | 166 | 219 | 193 |
| Working capital days | −23 | 29 | 49 | 70 | 92 | 94 | 98 | 102 | 83 | 88 | 125 | 59 |
| ROCE % | 24.0% | 18.0% | 14.0% | 17.9% | 17.9% | 14.0% | 21.0% | 14.9% | 0.0% | 6.0% | 0.0% | −6.0% |
For the Sep 2026 quarter, Quick Heal Technologies reported sales of ₹65.10 Cr, down 22.3% year on year and net profit of ₹5.81 Cr, down 26.7% year on year. The operating margin was 3.5%.
Quick Heal Technologies' sales for the year to Mar 2026 were ₹262 Cr; over the last twelve months they were ₹231 Cr.
Net profit for the year to Mar 2026 was −₹11.02 Cr, and −₹12.83 Cr over the last twelve months. Earnings per share over the same trailing period were ₹−2.36.
Quick Heal Technologies reported borrowings of ₹0 Cr at Mar 2026, against cash and equivalents of ₹13.02 Cr.
Cash from operations was ₹15.02 Cr in the year to Mar 2026; after capital spending, free cash flow was ₹5.99 Cr.